Stock ownership · SEC 13F · Q1 2025

INTRA CELLULAR THERAPIES INC COM

Who owns INTRA CELLULAR THERAPIES INC COM (CUSIP 46116X101)? A look at the institutions behind it, how tightly they hold it, and the latest quarter's moves.

$18.0M
Reported value
3
Institutions
100%
Top-5 share

The verdict

As of Q1 2025, 3 institutions report $18.0M in INTRA CELLULAR THERAPIES INC COM positions, ownership that is dominated by its top few institutional owners.

3
institutions hold it
$18.0M
reported 13F value
100%
held by top 5

Based on long positions reported to the SEC as of Q1 2025; 13F omits shorts, options and non-US holdings.

How 13F ownership is computed · All tracked stocks · Concentration rankings

SEC Form 13F-HR ownership desk

CUSIP 46116X101 · Q1 2025 $18M reported

VALUE-TRACE · HOLDERS-FOCUS · CONC-DOM · PHOTO-UNK · ACTIVITY-MID · BOOK-MID

  • VALUE-TRACE $18.0M
  • HOLDERS-FOCUS 3 filers
  • CONC-DOM 100% top-5
  • PHOTO-UNK No peer
  • ACTIVITY-MID 3 new
  • BOOK-MID 5Q history

Read with: Ownership concentration guide - INTRA CELLULAR THERAPIES INC COM's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.

Largest institutional holders of INTRA CELLULAR THERAPIES INC COM
  1. 1
    RHUMBLINE ADVISERS $16.5M
  2. 2
    STRS OHIO $970K
  3. 3
    JONES FINANCIAL COMPANIES LLLP $504K

Top 3 reported holders by value · Q1 2025

Institutional ownership over time

The number of institutions reporting a INTRA CELLULAR THERAPIES INC COM position has held steady from 3 to 3 over the last 5 quarters of 13F filings.

0.511.522.533.5 Q1'24Q2'24Q3'24Q4'24Q1'25 3
Distinct 13F filers holding INTRA CELLULAR THERAPIES INC COM, by quarter

Top Institutional Holders

# Institution Shares Value Share of reported
1 RHUMBLINE ADVISERS 125,239 $16.5M 91.8%
2 STRS OHIO 7,355 $970K 5.4%
3 JONES FINANCIAL COMPANIES LLLP 3,822 $504K 2.8%

Investment Discretion

SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among INTRA CELLULAR THERAPIES INC COM's reported holders for Q1 2025, by reported value:

Sole discretion (SOLE)
100.0%

Latest Quarter Activity · Q1 2025

New positions (3)

RHUMBLINE ADVISERS $16.5M
STRS OHIO $970K
JONES FINANCIAL COMPANIES LLLP $504K

Complete exits (2)

Universal- Beteiligungs- und Servicegesellschaft mbH exited
AMERIFLEX GROUP, INC. exited

Frequently Asked Questions

How many institutions hold INTRA CELLULAR THERAPIES INC COM?▼
INTRA CELLULAR THERAPIES INC COM is held by 3 institutional investors per the latest SEC Form 13F filings as of Q1 2025.
What is the total institutional value of INTRA CELLULAR THERAPIES INC COM?▼
Institutions report $18.0M of INTRA CELLULAR THERAPIES INC COM as of Q1 2025.
How concentrated is ownership of INTRA CELLULAR THERAPIES INC COM?▼
The top five institutional holders account for 100% of the reported institutional value in INTRA CELLULAR THERAPIES INC COM, making ownership dominated by its top few institutional owners.
Who is the largest institutional holder of INTRA CELLULAR THERAPIES INC COM?▼
RHUMBLINE ADVISERS is the largest reported holder of INTRA CELLULAR THERAPIES INC COM with $16.5M across 125,239 shares as of Q1 2025.

Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q1 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.

PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-16.